Indaptus Therapeutics, Inc. (INDP)
3.50
+0.41
(+13.27%)
USD |
NASDAQ |
Sep 22, 12:04
Indaptus Therapeutics Price : 3.50 for Sept. 22, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 21, 2026 | 3.55 | 3.55 | 2.90 | 3.09 | 719540.0 |
| Sep 18, 2026 | 3.85 | 4.090 | 3.51 | 3.55 | 1.164M |
| Sep 17, 2026 | 3.30 | 3.98 | 3.270 | 3.93 | 920856.0 |
| Sep 16, 2026 | 3.66 | 3.69 | 2.90 | 3.21 | 1.201M |
| Sep 15, 2026 | 3.40 | 3.695 | 3.05 | 3.64 | 1.960M |
| Sep 14, 2026 | 2.80 | 3.18 | 2.69 | 3.14 | 1.386M |
| Sep 11, 2026 | 2.70 | 2.94 | 2.46 | 2.77 | 1.802M |
| Sep 10, 2026 | 2.00 | 2.63 | 1.97 | 2.56 | 3.181M |
| Sep 09, 2026 | 1.92 | 2.39 | 1.89 | 2.08 | 5.676M |
| Sep 08, 2026 | 1.285 | 1.94 | 1.27 | 1.85 | 8.463M |
| Sep 04, 2026 | 1.20 | 1.235 | 1.17 | 1.22 | 133113.0 |
| Sep 03, 2026 | 1.16 | 1.19 | 1.14 | 1.16 | 249916.0 |
| Sep 02, 2026 | 1.17 | 1.20 | 1.131 | 1.17 | 331831.0 |
| Sep 01, 2026 | 1.10 | 1.162 | 1.10 | 1.13 | 75299.00 |
| Aug 31, 2026 | 1.14 | 1.17 | 1.09 | 1.145 | 140263.0 |
| Aug 28, 2026 | 1.16 | 1.184 | 1.10 | 1.14 | 104084.0 |
| Aug 27, 2026 | 1.13 | 1.24 | 1.09 | 1.16 | 404594.0 |
| Aug 26, 2026 | 1.09 | 1.16 | 1.06 | 1.14 | 206024.0 |
| Aug 25, 2026 | 1.15 | 1.18 | 1.09 | 1.095 | 497159.0 |
| Aug 24, 2026 | 1.24 | 1.29 | 1.13 | 1.16 | 293729.0 |
| Aug 21, 2026 | 1.39 | 1.58 | 1.18 | 1.29 | 1.138M |
| Aug 20, 2026 | 0.9419 | 1.42 | 0.94 | 1.38 | 11.75M |
| Aug 19, 2026 | 0.9361 | 1.11 | 0.925 | 0.94 | 813176.0 |
| Aug 18, 2026 | 1.00 | 1.02 | 0.92 | 0.9361 | 341447.0 |
| Aug 17, 2026 | 1.10 | 1.24 | 0.9801 | 1.00 | 359563.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 26.63 |
| Alnylam Pharmaceuticals, Inc. | 253.42 |
| Anika Therapeutics, Inc. | 20.88 |
| Savara, Inc. | 5.44 |
| Vericel Corp. | 39.94 |
Price Related Metrics
| Price to Book Value | 41.01 |
| Earnings Yield | -199.3% |
| Market Cap | 466.35M |